<?xml version="1.0" encoding="UTF-8"?>
<p>Pre‐eclampsia affects 2–8% of pregnancies worldwide and is one of the leading causes of maternal death and perinatal mortality and morbidity
 <xref rid="uog22049-bib-0008" ref-type="ref">8</xref>. Currently, around the world, there are more than 350 536 active cases of COVID‐19 and this number is increasing every day
 <xref rid="uog22049-bib-0009" ref-type="ref">9</xref>. On the other hand, there are fewer than 100 published cases of COVID‐19 in pregnant women. Based on these case series and reports, it appears that the natural history of SARS‐CoV‐2 infection among pregnant women is not different from that in non‐pregnant adults. A World Health Organization (WHO) report from China states that only 1% of the described cases in pregnant women have been critical and 8% were severe
 <xref rid="uog22049-bib-0010" ref-type="ref">10</xref>. At the time of writing, there were no reported maternal deaths related to SARS‐CoV‐2 infection. None of the cases of COVID‐19 in pregnant women in the series of Schwartz was severe
 <xref rid="uog22049-bib-0011" ref-type="ref">11</xref>.
</p>
